微流控精子制备用于ICSI的胚胎质量与密度梯度离心相似:一项实用性随机对照试验
该前瞻性随机对照试验纳入386例计划行IVF的患者,比较微流控精子分离装置与密度梯度离心处理精子对ICSI胚胎质量的影响。意向性分析显示两组优质卵裂期胚胎比例和优质囊胚比例均无显著差异,临床妊娠率和持续妊娠率亦无差异。
要点
- 微流控精子制备组与密度梯度离心组的优质卵裂期胚胎比例无显著差异。
- 两组优质囊胚比例、临床妊娠率和持续妊娠率均无显著差异。
- 研究人群未筛选男性因素不孕或精子DNA碎片升高者。
核心结论
- 在未筛选人群中,微流控精子分离用于IVF精子制备的效果与密度梯度离心相似。
研究设计与样本
- 前瞻性随机对照试验,2017年6月至2021年9月纳入386例计划行IVF的患者,在学术医疗中心进行。
- 192例分配至微流控精子分离装置组,194例分配至临床标准密度梯度离心对照组。
主要发现
- 意向性分析中,优质卵裂期胚胎比例对照组为66.0(25.8)%,微流控精子制备组为68.0(30.3)%,P=0.541,绝对差-2.0,95%CI(-8.5,4.5)。
- 优质囊胚比例对照组为37.4(25.4)%,微流控精子制备组为37.4(26.2)%,P=0.985,绝对差-0.6,95%CI(-6,5.9)。
- 两组临床妊娠率和持续妊娠率均无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究人群为 inclusive 人群,未尝试分离男性因素不孕病例或精子DNA碎片升高病史患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does processing of spermatozoa for IVF with ICSI by a microfluidic sperm separation device improve embryo quality compared with density-gradient centrifugation? SUMMARY ANSWER: Patients randomized to microfluidic sperm preparation had similar cleavage- and blastocyst-stage embryo quality and clinical and ongoing pregnancy rates to those who underwent standard sperm processing for IVF with ICSI. WHAT IS KNOWN ALREADY: Microfluidic sperm preparation can isolate spermatozoa for clinical use with minimal DNA fragmentation but with unclear impact on clinical outcomes. STUDY DESIGN, SIZE, DURATION: A prospective randomized controlled trial of 386 patients planning IVF from June 2017 through September 2021 was carried out. PARTICIPANTS/MATERIALS, SETTING, METHODS: One hundred and ninety-two patients were allocated to sperm processing with a microfluidic sperm separation device for ICSI, while 194 patients were allocated to clinical standard density-gradient centrifugation (control) at an academic medical centre. MAIN RESULTS AND THE ROLE OF CHANCE: In an intention to treat analysis, there were no differences in high-quality cleavage-stage embryo fraction [66.0 (25.8)% control versus 68.0 (30.3) microfluidic sperm preparation, P = 0.541, absolute difference -2.0, 95% CI (-8.5, 4.5)], or high-quality blastocyst fraction [37.4 (25.4) control versus 37.4 (26.2) microfluidic sperm preparation, P = 0.985, absolute difference -0.6 95% CI (-6, 5.9)] between groups. There were no differences in the clinical pregnancy or ongoing pregnancy rates between groups. LIMITATIONS, REASONS FOR CAUTION: The population studied was inclusive and did not attempt to isolate male factor infertility cases or patients with a history of elevated sperm DNA fragmentation. WIDER IMPLICATIONS OF THE FINDINGS: Microfluidic sperm separation performs similarly to density-gradient centrifugation in sperm preparation for IVF in an unselected population. STUDY FUNDING/COMPETING INTEREST(S): No external funding to declare. M.P.R. is a member of the Clinical Advisory Board for ZyMōt® Fertility, Inc. TRIAL REGISTRATION NUMBER: NCT03085433. TRIAL REGISTRATION DATE: 21 March 2017. DATE OF FIRST PATIENT’S ENROLLMENT: 16 June 2017.
引用
- Quinn MM, Ribeiro S, Juarez-Hernandez F, et al. Microfluidic preparation of spermatozoa for ICSI produces similar embryo quality to density-gradient centrifugation: a pragmatic, randomized controlled trial. Hum Reprod. 2022. PMID: 35522187. doi:10.1093/humrep/deac099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。